NCT00622115View on ClinicalTrials.gov

Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)

PHASE1CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Thrombosis

Interventions

DRUG

Enoxaparin

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00622115 - Etude (Study) Phase I Enox - UnFractionated Heparin (UFH) | Biotech Hunter | Biotech Hunter